Pregnancy Complications May Signal a Woman’s Future Heart Risk

Women who experience problems such as high‑blood‑pressure disorders, gestational diabetes, or preterm birth during pregnancy are more likely to develop heart disease later in life. New research frames these complications as an early warning system, urging health systems to track cardiovascular health after birth and to bring community blood‑pressure checks to underserved neighborhoods.

Key takeaways

• Pregnancy acts like a stress test for the heart; complications can reveal hidden risk for later cardiovascular disease [1].
• Hypertensive disorders of pregnancy, gestational diabetes, and preterm birth are linked to higher long‑term heart‑disease rates [1,2].
• Current risk‑assessment tools do not fully capture the added danger from these pregnancy complications [1].
• Large community‑based hypertension‑screening programs are being tested to catch early blood‑pressure problems, especially in underserved areas [3].
• Researchers call for more studies on how best to follow women after adverse pregnancy outcomes and on prevention strategies tailored to this group [1,2].

Why pregnancy matters for the heart

During pregnancy a woman’s circulatory system works much harder. Blood volume rises, the heart beats faster, and vessels must expand to support the growing fetus. This physiological challenge can expose weaknesses in the cardiovascular system that might stay hidden otherwise [1]. When a pregnancy is complicated by high blood pressure (hypertensive disorders of pregnancy), high blood sugar (gestational diabetes), or an early birth (preterm delivery), it suggests that the woman’s heart and blood vessels may already be vulnerable [1,2].

The Lancet review points out that these adverse pregnancy outcomes (APOs) are not isolated events. Women who experience them face a higher chance of developing heart disease, stroke, or kidney problems later in life [1]. The authors argue that APOs should be treated as “sex‑specific indicators” of future risk, offering a chance to intervene earlier than current guidelines allow [1].

Gaps in current risk assessment

Standard cardiovascular risk calculators focus on age, cholesterol, smoking, and blood pressure. They rarely include a woman’s pregnancy history [1]. Because of this omission, many women with APOs are underestimated for future heart risk [1]. The Lancet series on cardiovascular disease in pregnancy highlights that the tools used today “have limitations” and that there is “uncertainty about optimal follow‑up models” for women after an APO [2].

Researchers also note a lack of prevention trials that target women with a history of APOs [1]. Without trial data, it is hard to know which lifestyle changes or medications might best lower the long‑term risk for this group. This knowledge gap fuels calls for “mechanistic and implementation research” to test new approaches [1].

Community screening as a possible early‑intervention model

One concrete effort to catch cardiovascular problems early is a community‑based hypertension‑screening program underway in French Guiana’s low‑income urban neighborhoods [3]. High blood pressure is a leading cause of stroke and heart disease, especially in underserved populations. The study plans to enroll over 10,000 residents, provide blood‑pressure checks through community health workers, and follow participants with phone calls for several months [3].

Although the trial does not focus exclusively on women with APOs, its design illustrates how “scalable, community‑mediated” screening could reach people who might otherwise miss routine doctor visits [3]. If the program shows a reduction in stroke rates, it could serve as a model for postpartum follow‑up that includes blood‑pressure monitoring for women flagged by an APO history.

What remains uncertain

Even with growing evidence, several questions linger. The Lancet review lists key knowledge gaps: the best timing and frequency of postpartum cardiovascular check‑ups are unknown, and existing risk‑stratification tools need refinement to incorporate APO data [1]. Moreover, the series on pregnancy and cardiovascular disease emphasizes that global disparities affect how well women are monitored after complications, suggesting that equity‑focused strategies are essential [2].

Finally, while community screening shows promise, the French Guiana study will not report results until 2026 [3]. Until then, it is unclear how effective such programs will be in preventing heart attacks or strokes, especially among women whose pregnancy flagged future risk.

Looking ahead

The emerging view of pregnancy as a “window into lifelong heart health” urges health systems to record APOs and to consider them when planning long‑term care [1,2]. Large‑scale community blood‑pressure checks may become a practical way to catch early signs of cardiovascular trouble, particularly in neighborhoods where regular medical visits are hard to obtain [3].

More research is needed to design follow‑up models that truly lower heart disease rates for women with a history of pregnancy complications. Until those studies are complete, clinicians and policymakers will continue to weigh how best to turn early warning signs into effective prevention.